These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 39384957)
1. The role of the S100A8/S100A9 in gastric tumor progression. Fang S; Du S; Luo X; Qing X; Wang L; Ban Y; Song G; Yang Y; Wei W Sci Rep; 2024 Oct; 14(1):23574. PubMed ID: 39384957 [TBL] [Abstract][Full Text] [Related]
2. S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice. Ji X; Nie C; Yao Y; Ma Y; Huang H; Hao C PeerJ; 2024; 12():e17106. PubMed ID: 38646478 [TBL] [Abstract][Full Text] [Related]
3. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243 [TBL] [Abstract][Full Text] [Related]
4. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Yong HY; Moon A Arch Pharm Res; 2007 Jan; 30(1):75-81. PubMed ID: 17328245 [TBL] [Abstract][Full Text] [Related]
5. Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. Fan B; Zhang LH; Jia YN; Zhong XY; Liu YQ; Cheng XJ; Wang XH; Xing XF; Hu Y; Li YA; Du H; Zhao W; Niu ZJ; Lu AP; Li JY; Ji JF BMC Cancer; 2012 Jul; 12():316. PubMed ID: 22838504 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells. Lim SY; Yuzhalin AE; Gordon-Weeks AN; Muschel RJ Oncogene; 2016 Nov; 35(44):5735-5745. PubMed ID: 27086923 [TBL] [Abstract][Full Text] [Related]
7. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827 [TBL] [Abstract][Full Text] [Related]
8. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907 [TBL] [Abstract][Full Text] [Related]
9. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms. Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821 [TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 activate key genes and pathways in colon tumor progression. Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy. Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551 [TBL] [Abstract][Full Text] [Related]
12. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Kwon CH; Moon HJ; Park HJ; Choi JH; Park DY Mol Cells; 2013 Mar; 35(3):226-34. PubMed ID: 23456298 [TBL] [Abstract][Full Text] [Related]
14. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation. Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424 [TBL] [Abstract][Full Text] [Related]
15. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells. Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228 [TBL] [Abstract][Full Text] [Related]
16. S100A9 Gong C; Ma J; Deng Y; Liu Q; Zhan Z; Gan H; Xiang X; Zhang M; Cao K; Shen T; Fang L; Shen B; Shen S; Ding S Biomed Pharmacother; 2024 Mar; 172():116233. PubMed ID: 38308971 [TBL] [Abstract][Full Text] [Related]
17. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424 [TBL] [Abstract][Full Text] [Related]
18. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849 [TBL] [Abstract][Full Text] [Related]
19. Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L Front Immunol; 2021; 12():658681. PubMed ID: 34093546 [No Abstract] [Full Text] [Related]
20. [Clinical significance of S100A8 and S100A9 expression in gastric cancer]. Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]